Efficacy and Safety of Approved First-Line Tyrosine Kinase Inhibitor Treatments in Metastatic Renal Cell Carcinoma: A Network Meta-Analysis

INTRODUCTION: This network meta-analysis aims to deliver an up-to-date, comprehensive efficacy and toxicity comparison of the approved first-line tyrosine kinase inhibitors (TKIs) for metastatic renal cell carcinoma (mRCC) in order to provide support for evidence-based treatment decisions. Previous...

Descripción completa

Detalles Bibliográficos
Autores principales: Manz, Kirsi M., Fenchel, Klaus, Eilers, Andreas, Morgan, Jonathan, Wittling, Kirsten, Dempke, Wolfram C. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004428/
https://www.ncbi.nlm.nih.gov/pubmed/31838709
http://dx.doi.org/10.1007/s12325-019-01167-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004428/
https://www.ncbi.nlm.nih.gov/pubmed/31838709
http://dx.doi.org/10.1007/s12325-019-01167-2

Ejemplares similares